{
    "nctId": "NCT03065478",
    "briefTitle": "Observational STudy to Evaluate the EFfectiveness of OnLife\u00ae in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy",
    "officialTitle": "An Observational STudy to Evaluate the EFfectiveness of OnLife\u00ae in Improving Chemotherapy-induced peripherAl NeurOpathy in Patients With Colon or Breast Cancer After End of Adjuvant Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "CIPN in Adjuvant Colon Cancer Patients, CIPN in Adjuvant Breast Cancer Patients",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Evaluation of the CIPN",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients with colon or breast cancer that have finished adjuvant oxaliplatin-containing or paclitaxel chemotherapy, respectively\n* End of adjuvant chemotherapy does not date back more than 4 months\n* Presence of CIPN grade 1-3 (according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.03)\n* Decision for treatment with OnLife\u00ae (Baseline assessment has to be done before first intake of OnLife\u00ae)\n* Written informed consent\n* Able to understand and willing to complete study and patient-reported assessment instruments\n\nExclusion Criteria:\n\n* Presence of sensory and/or motor disturbances due to other neurological diseases\n* Alcohol abuse\n* Pregnancy or breast-feeding\n* Severe difficulty swallowing\n* Intolerance to one of the ingredients of OnLife\u00ae",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}